Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 - Healthsport, Inc. | c99219exv31w2.htm |
EX-32.2 - EXHIBIT 32.2 - Healthsport, Inc. | c99219exv32w2.htm |
EX-10.1 - EXHIBIT 10.1 - Healthsport, Inc. | c99219exv10w1.htm |
EX-32.1 - EXHIBIT 32.1 - Healthsport, Inc. | c99219exv32w1.htm |
EX-31.1 - EXHIBIT 31.1 - Healthsport, Inc. | c99219exv31w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q/A
(Amendment No. 1)
þ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended June 30, 2009
or
o | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to
Commission File Number: 000-23100
HEALTHSPORT, INC.
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
22-2649848 (I.R.S. Employer Identification No.) |
|
1620 Beacon Place Oxnard, California (Address of principal executive offices) |
93033 (Zip Code) |
(818) 593-4880
(Registrants telephone number, including area code)
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files).
Yes
o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check
one):
Large accelerated filer o | Accelerated filer o | Non-accelerated filer o | Smaller reporting company þ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No þ
EXPLANATORY NOTE
HealthSport, Inc. (the Company) is filing this Amendment No. 1 to its Quarterly Report on
Form 10-Q for the quarterly period ended June 30, 2009 (the Original Quarterly Report) for the
sole purpose of (1) adding a footnote to the exhibit index of the Original Quarterly Report to
disclose that portions of Exhibit 10.1 to the Original Quarterly Report (Exhibit 10.1) have been
omitted pursuant to a confidential treatment request and (2) re-filing Exhibit 10.1. The Company
is re-filing Exhibit 10.1 in response to comments received from the Securities and Exchange
Commission (the Commission) in response to a confidential treatment request that the Company
submitted to the Commission in connection with a request for confidential treatment of portions of
Exhibit 10.1. The Company has made no other changes to the previously filed Original Quarterly
Report.
This Amendment does not reflect events occurring after the filing of the Original Quarterly
Report or modify or update those disclosures affected by subsequent events. Except as described
above, no other modifications or changes have been made to the Original Quarterly Report as
originally filed. Other events occurring after the filing of the Original Quarterly Report or other
disclosures necessary to reflect subsequent events have been addressed in our reports filed with
the Securities and Exchange Commission subsequent to the filing of the Original Quarterly Report.
-2-
PART II
OTHER INFORMATION
OTHER INFORMATION
Item 6. | Exhibits |
Exhibit Index
Exhibit | ||||||
No. | Document Description | Incorporation by Reference | ||||
10.1 | * | Manufacturing License
Agreement dated August 13,
2009 between InnoZen, Inc. and
Supplemental Manufacturing
Ingredients, Inc.
|
Filed herewith. | |||
31.1 | Certification of Principal
Executive Officer pursuant to
Rule 13a-14(a) or 15d-14(a) of
the Securities Exchange Act of
1934, as adopted pursuant to
Section 302 of the
Sarbanes-Oxley Act of 2002.
|
Filed herewith. | ||||
31.2 | Certification of Principal
Financial Officer pursuant to
Rule 13a-14(a) or 15d-14(a) of
the Securities Exchange Act of
1934, as adopted pursuant to
Section 302 of the
Sarbanes-Oxley Act of 2002.
|
Filed herewith. | ||||
32.1 | Certification of Principal
Executive Officer pursuant to
18 U.S.C. Section 1350, as
adopted pursuant to Section
906 of the Sarbanes-Oxley Act
of 2002.
|
Filed herewith. | ||||
32.2 | Certification of Principal
Financial Officer pursuant to
18 U.S.C. Section 1350, as
adopted pursuant to Section
906 of the Sarbanes-Oxley Act
of 2002.
|
Filed herewith. |
* | Confidential portions of this exhibit have been omitted and are filed separately with the
Securities and Exchange Commission pursuant to a confidential treatment request. |
-3-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HEALTHSPORT, INC. | ||||
Date: April 14, 2010
|
/s/ Kevin Taheri
|
|||
(Duly Authorized Officer and Principal Executive Officer) |
-4-